Abilify and Impulsive behaviour for Men aged 30-39 (a phase IV clinical study of FDA data)

Summary:

Impulsive behaviour is found for men aged 30-39 who take Abilify (aripiprazole). This study is created by eHealthMe based on reports of 3,798 men aged 30-39 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Abilify when people have Impulsive behaviour
Top conditions
Top co-used drugs
Top other side effects

On Mar, 19, 2026

3,798 men aged 30-39 reported to have side effects when taking Abilify.
Among them, 16 people (0.42%) have Impulsive behaviour

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,450 Abilify users. Check the latest studies of Abilify.

What is Impulsive behaviour?

Impulsive behaviour is found to be associated with 550 drugs and 577 conditions by eHealthMe. Check the latest studies of Impulsive behaviour.

Number of reports submitted per year:

Could Abilify cause Impulsive behaviour in men aged 30-39?

Time on Abilify when people have Impulsive behaviour *

Severity of Impulsive behaviour

n/a

How people recovered from Impulsive behaviour

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Stress And Anxiety: 7 people, 43.75%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 25.00%
Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 3 people, 18.75%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 18.75%
Liver Disorder (liver diseases): 3 people, 18.75%
Psychotic Disorder: 3 people, 18.75%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 3 people, 18.75%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 12.50%
Sleep Disorder: 2 people, 12.50%
Borderline Personality Disorder: 2 people, 12.50%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 9 people, 56.25%
Stress And Anxiety: 9 people, 56.25%
Gambling: 7 people, 43.75%
Suicidal Ideation: 7 people, 43.75%
Loss Of Employment: 6 people, 37.50%
Emotional Distress: 6 people, 37.50%
Eating Disorder: 5 people, 31.25%
Injury: 5 people, 31.25%
Suicide Attempt: 5 people, 31.25%
Compulsive Sexual Behavior: 5 people, 31.25%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Impulsive behaviour?

- Check whether Impulsive behaviour is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies:

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

Related studies:

Abilify and Impulsive behaviour

How the study uses the data?

The study is based on (applicable) gender, age, aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.